ClinicalTrials.Veeva

Menu

Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)

C

Centre Hospitalier de Saint-Denis

Status

Completed

Conditions

Meningitis
Toxoplasmosis
Central Nervous System Infections
HIV Infections
Cerebrospinal Fluid
Toxoplasmosis, Cerebral

Study type

Observational

Funder types

Other

Identifiers

NCT07044037
0076_NEUROLOGIE

Details and patient eligibility

About

This study looks at patients who were treated for cerebral toxoplasmosis at CHSD between 2004 and 2024. It focuses on analyzing their cerebrospinal fluid (CSF) to better understand the biological signs of the disease. The goal is to see if CSF results can show signs of meningitis, even though it's not commonly reported, and to describe any co-infections, symptoms, brain imaging findings, and patient outcomes.

Enrollment

53 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (age 18 years) hospitalized at CHSD between January 1, 2004 and March 31, 2024 for cerebral toxoplasmosis

Exclusion criteria

  • Under 18 years ols

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems